P/E at 65.63 vs Industry's 65.45: What the Data Shows for Apollo Hospitals Enterprise Ltd.

Valuation Picture: Premium or Parity?

The current P/E of Apollo Hospitals Enterprise Ltd. stands at 65.63, marginally above the hospital industry average of 65.45. This near-equal valuation suggests that the market is pricing the stock in line with its sector peers, reflecting neither a significant premium nor a discount. Such a valuation level is notable given the company’s large-cap status with a market capitalisation of ₹1,27,053.87 crores, indicating investor confidence in its earnings stability and growth prospects relative to the broader hospital sector.

However, this parity in valuation does not imply uniform performance across the sector. The hospital industry’s P/E has been relatively stable, but individual stock trajectories vary widely. Apollo Hospitals Enterprise Ltd.’s P/E ratio suggests that the market is factoring in its premium brand and operational scale, but the question remains — previously rated Hold, what is Apollo Hospitals’ current rating? The subtle valuation premium invites a closer look at performance metrics and technical indicators to understand the underlying momentum.

Performance Across Timeframes: A Tale of Consistent Outperformance

Examining returns over multiple periods reveals a strong performance narrative for Apollo Hospitals Enterprise Ltd.. Over the past year, the stock has gained 20.02%, significantly outperforming the Sensex’s 7.61% decline. Year-to-date, the stock’s return of 25.47% contrasts sharply with the Sensex’s 10.91% fall, underscoring its resilience amid broader market weakness.

Shorter-term returns also paint a positive picture. Over three months, the stock rose 14.38%, while the Sensex dipped 0.96%. The one-month gain of 3.07% further highlights recent momentum, with the stock outperforming the Sensex’s 1.38% decline. Even the one-week performance shows a modest 0.17% increase against a 2.85% drop in the benchmark index.

Despite this, the stock has experienced a slight pullback in the last two days, losing 1.49% cumulatively and underperforming the sector by 0.57% today. This short-term softness raises the question — is this a temporary correction or a sign of waning momentum? The data suggests a need to balance the strong medium-term gains with recent volatility.

Moving Average Configuration: Signs of a Controlled Uptrend

The technical setup for Apollo Hospitals Enterprise Ltd. reveals a nuanced trend. The stock is trading above its 20-day, 50-day, 100-day, and 200-day moving averages, signalling a sustained upward momentum over the medium to long term. However, it remains below the 5-day moving average, indicating some short-term hesitation or consolidation.

This configuration suggests that while the stock has enjoyed a recovery and is maintaining strength relative to longer-term averages, the immediate price action is showing signs of a pause. The 5-day moving average acts as a near-term resistance level, and the recent two-day consecutive decline of 1.49% may reflect profit-taking or a technical correction. The 5-day dip partially reverses recent gains — is this a genuine recovery or a relief rally that will fade at the 50 DMA? The moving average configuration provides the clearest answer.

Sector Performance Context: Hospital Industry Trends

The hospital sector has experienced mixed results recently, with some stocks showing robust gains while others remain flat or negative. Within this context, Apollo Hospitals Enterprise Ltd. stands out as a large-cap leader with consistent outperformance. Its ability to maintain a P/E ratio in line with the industry average while delivering strong returns highlights its operational strength and market positioning.

Sector-wide, the hospital industry has seen a blend of positive, flat, and negative performers, reflecting varied responses to regulatory changes, patient volumes, and cost pressures. Against this backdrop, Apollo Hospitals Enterprise Ltd.’s steady gains and technical resilience underscore its relative stability. This raises the question — should investors in Apollo Hospitals hold, buy more, or reconsider?

Rating Reassessment: From Hold to a New Evaluation

On 11 May 2026, Apollo Hospitals Enterprise Ltd.’s rating was updated from Hold, reflecting a reassessment of its fundamentals and technicals. The previous Mojo Score of 75.0 and the large-cap market cap grade underpin the company’s strong market standing. This rating change coincides with the stock’s robust multi-year performance, including a 3-year return of 70.89%, a 5-year return of 125.58%, and an impressive 10-year return of 561.38%, all substantially outperforming the Sensex over the same periods.

The rating update invites investors to consider the implications of the stock’s valuation and performance metrics in tandem. The question remains — what is the current rating for Apollo Hospitals Enterprise Ltd.? The data-driven reassessment reflects a comprehensive view of the company’s market position and technical signals.

Conclusion: A Balanced View of Valuation and Momentum

The data for Apollo Hospitals Enterprise Ltd. presents a compelling narrative of valuation parity with its sector, strong medium- to long-term performance, and a technical setup that suggests cautious optimism. The stock’s P/E ratio closely mirrors the hospital industry average, indicating that the market is neither overly exuberant nor dismissive. Its consistent outperformance over one, three, and five years, alongside a solid moving average configuration, supports the view of a fundamentally sound and technically resilient stock.

Short-term fluctuations, including the recent two-day decline and the position below the 5-day moving average, highlight the importance of monitoring momentum closely. The sector’s mixed performance adds further context to the stock’s relative strength. Investors may find value in analysing these data points collectively — should Apollo Hospitals be held, increased, or reconsidered in portfolios?

Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →